Bill

Bill > S2757


NJ S2757

NJ S2757
Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.


summary

Introduced
02/15/2024
In Committee
02/15/2024
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill requires health insurers (health, hospital, and medical service corporations, commercial individual and group health insurers, health maintenance organizations, health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program) to provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.

AI Summary

This bill mandates that various health insurance providers in New Jersey, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurers, health maintenance organizations (HMOs), and plans under the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, as well as the State Health Benefits Program and the School Employees' Health Benefits Program, must cover the costs associated with purchasing and using a continuous glucose monitoring system when prescribed by a healthcare professional for the treatment of glycogen storage disease, ensuring these benefits are provided to the same extent as for other medical conditions.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 02/15/2024)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...